Vericel (VCEL) Reports Q2 Loss of $0.12/Share

Go back to Vericel (VCEL) Reports Q2 Loss of $0.12/Share

Vericel Corporation (VCEL) PT Lowered to $14 at Needham & Company, Keeps 'Buy'

August 7, 2018 9:14 AM EDT

Needham & Company lowered its price target on Vericel Corporation (NASDAQ: VCEL) to $14.00 (from $15.00) while maintaining a Buy rating.

Analyst Chad Messer commented, "Vericel reported $19.0M in net product sales including $14.1M in MACI sales and $4.9M for Epicel. Our estimate was... More